Wednesday, March 29, 2017 11:03:40 PM
Source: Full News Release
Earlier this month Health Advance (OTC PINK: HADV), a U.S. based developer and distributor of pharmaceutical and nutritional products, announced its endeavors on this generally recognized as safe (also known as GRAS) by the US Food and Drug Administration (FDA) product development of medical foods containing ibuprofen and botanical extract blends derived from mitragyna speciosa, kava, and cannabidiol to treat pain and severe illness.
#organicmedicine, #dietarysupplements #consumers, #investors, #gwpharm, #cannabidiol, #kratom, #mitragynaspeciosa, #kava, #oxycodone, #hydrocodone, #buprenorphine, #oxymorphone, #hydromorphone, #ibuprofen, #botanicalextracts
$HADV $GWPH
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM